title: Clinical assessment of human gonadotrophins produced by recombinant DNA technology.
authors.affiliation: Corporate Medical Affairs Department, Ares-Serono, Geneva, Switzerland.
authors.forename: E
authors.initials: E
authors.lastname: Loumaye
authors.forename: I
authors.initials: I
authors.lastname: Martineau
authors.forename: A
authors.initials: A
authors.lastname: Piazzi
authors.forename: L
authors.initials: L
authors.lastname: O'Dea
authors.forename: S
authors.initials: S
authors.lastname: Ince
authors.forename: C
authors.initials: C
authors.lastname: Howles
authors.forename: G
authors.initials: G
authors.lastname: Decosterd
authors.forename: K
authors.initials: K
authors.lastname: Van Loon
authors.forename: A
authors.initials: A
authors.lastname: Galazka
mesh_terms: D000818:Animals; D016466:CHO Cells; D006063:Chorionic Gonadotropin / Q000096:biosynthesis / Q000235:genetics* / Q000627:therapeutic use; D006224:Cricetinae; D004353:Drug Evaluation, Preclinical; D005260:Female; D005640:Follicle Stimulating Hormone / Q000096:biosynthesis / Q000235:genetics* / Q000627:therapeutic use; D005818:Genetic Engineering; D006801:Humans; D007986:Luteinizing Hormone / Q000096:biosynthesis / Q000235:genetics* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000627:therapeutic use
chemical_list: D006063:Chorionic Gonadotropin; D011994:Recombinant Proteins; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone